Clinical trial
Thymus Transplantation Dose in DiGeorge #932
NCT00576836 · Sumitomo Pharma Switzerland GmbH, Industry · Completed
Key facts
| NCT number | NCT00576836 |
|---|---|
| Title | Thymus Transplantation Dose in DiGeorge #932 |
| Official title | Dose Study of Thymus Transplantation in DiGeorge Anomaly, IND 9836, #932.1 |
| Lead sponsor | Sumitomo Pharma Switzerland GmbH, Industry |
| Collaborators | National Institutes of Health (NIH) NIH National Institute of Allergy and Infectious Diseases (NIAID) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | DiGeorge Anomaly, DiGeorge Syndrome, Complete DiGeorge Anomaly, Complete DiGeorge Syndrome |
| Intervention type | Biological, Other |
| Interventions | Cultured Thymus Tissue Implantation (CTTI), Cultured Thymus Tissue Implantation with Parathyroid Transplantation |
| Enrollment | 7 |
| Start date | Sep 2, 2004 |
| Primary completion | Nov 1, 2010 |
| Completion | Dec 31, 2019 |
| First posted | Dec 19, 2007 |
| Last update posted | Mar 25, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: